Literature DB >> 10195678

Tuberculosis epidemiology and control in Veracruz, Mexico.

M L García-García1, P M Small, C Garcia-Sancho, M E Mayar-Maya, L Ferreyra-Reyes, M Palacios-Martinez, S Jiménez, G Canales, G Quiroz, L Yáñez, J L Valdespino-Gómez.   

Abstract

BACKGROUND: Tuberculosis (TB) rates remain high in regions of Southern Mexico despite the existence of a National Tuberculosis Program. Understanding TB epidemiology in such settings would assist in the design of improved TB control and highlight the challenges confronting TB control in developing countries.
METHODS: We conducted a retrospective review of treatment control cards from 1991 to 1994 in five municipalities in a semiurban region of Southern Mexico.
RESULTS: The relatively high rate of TB observed, 42.6 per 100,000 inhabitants, did not change significantly during the study period. Cure rates among new cases were 79% and significantly lower among retreatment cases (62%). Directly observed therapy (DOT) was administered to 84% of patients. Approximately one-half of the retreatment cases who were not cured were compliant with therapy, suggesting that drug resistance contributed to these poor results. Of particular concern was a core group of 16 patients who had received at least three treatments.
CONCLUSIONS: This region of Mexico has persistently high TB rates despite a DOT-based TB control programme which achieves an overall cure rate of 77%. There exist many retreatment cases for whom cure rates are significantly lower. These cases may serve as a core group for the dissemination of drug resistant TB. The control programme is being reinforced by a nominal register of patients, decreasing administrative barriers for drug supply to individual patients and the availability of mycobacteria cultures. In addition to these measures, in regions which are approaching the levels of efficacy recommended by the WHO it may be appropriate to consider focusing efforts on the identification and treatment of chronic cases.

Entities:  

Mesh:

Year:  1999        PMID: 10195678     DOI: 10.1093/ije/28.1.135

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  4 in total

1.  Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment.

Authors:  K Middelkoop; L-G Bekker; E Shashkina; B Kreiswirth; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-14       Impact factor: 2.373

2.  Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model.

Authors:  Brenda Marquina-Castillo; Lourdes García-García; Alfredo Ponce-de-León; Maria-Eugenia Jimenez-Corona; Miriam Bobadilla-Del Valle; Bulmaro Cano-Arellano; Sergio Canizales-Quintero; Areli Martinez-Gamboa; Midori Kato-Maeda; Brian Robertson; Douglas Young; Peter Small; Gary Schoolnik; Jose Sifuentes-Osornio; Rogelio Hernandez-Pando
Journal:  Immunology       Date:  2008-12-22       Impact factor: 7.397

3.  Cost-effectiveness of treating multidrug-resistant tuberculosis.

Authors:  Stephen C Resch; Joshua A Salomon; Megan Murray; Milton C Weinstein
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

4.  Tuberculosis-related deaths within a well-functioning DOTS control program.

Authors:  Maria De Lourdes García-García; Alfredo Ponce-De-León; Maria Cecilia García-Sancho; Leticia Ferreyra-Reyes; Manuel Palacios-Martínez; Javier Fuentes; Midori Kato-Maeda; Miriam Bobadilla; Peter Small; José Sifuentes-Osornio
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.